Revenue
Margin
Demand
Guidance
Tone
Event Participants
Executives
5 A.K. Khindra, Anshuman Singhania, Arun K. Bajoria, Bharat Aggarwal, Sanjeev Aggarwal
Analysts
5 Aditi Prajapati, Bharat Bhagnani, Chirag Jain, Digant Shah, Vijay Kumar
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue (Consolidated) | ₹3,956 crore | +2% YoY vs ₹3,891 crore in Q1 FY26; steady performance led by strong volume growth, partly offset by raw material price pressures |
| Domestic Volume Growth | +25% YoY | Led by OEM +42%, replacement growth across all segments; standalone volume growth mid-single digit QoQ |
| EBITDA | ₹268 crore | Down from ₹424 crore in Q1 FY26; impacted by ~20% QoQ spike in raw material costs from West Asia crisis |
| EBITDA Margin | 6.8% | vs 10.9% in Q1 FY26; gross margin pressure from raw material inflation, partially offset by price hikes and operating leverage |
| Profit After Tax | ₹43 crore | Cash profit ₹169 crore vs ₹309 crore YoY |
| EPS (Consolidated) | ₹1.55 | vs ₹6.03 in Q1 FY26 |
| Net Debt | ₹4,945 crore | +₹500 crore QoQ; driven by CapEx-led long-term loan disbursements and higher working capital due to elevated raw material/selling prices and volumes |
| Net Debt-to-Equity | 0.81x | Comfortable leverage zone; Net debt-to-EBITDA at 2.56x |
| Capacity Utilization | ~95% Standalone | ~80% consolidated; TBR near full, PCR 95%, 2-3W near full, LCV/farm 95%+ |
| Price Increases | ~5% in Q1 | Cumulative ~11% taken to date; further 5-6% planned going forward |
Geographic & Segment Commentary
- India Domestic: Volume growth of 25% YoY driven by OEM +42% and strong replacement demand; standalone revenue growth ~14% with net effective price increase of ~5%. Product mix improving with PCR 16-inch+ at ~35% of PCR volumes; all installed capacities fully utilized.
- Mexico (Tornel): Q1 FY27 operations disrupted by geopolitical supply chain constraints (bead wire from China, container cost surge, natural rubber +18%) and productivity enhancement slowdown (not a strike) with workers — now resolved with production normalized. Expecting better top-line and bottom-line in remaining three quarters; similar revenue level as prior year targeted by year-end.
- Exports (from India): Volumes steady despite geopolitical uncertainty, +2% QoQ over Q4 FY26; newly signed FTAs with EU/UK expected to strengthen export penetration.
- Product Mix (Standalone volumes): TBR 56%, PCR 27%, Two/Three-wheeler 5%, Others (industrial/farm) 12%; premiumization trend continuing.
- EV Segment: Overall EV volumes grew double-digit QoQ; full-stack EV tyre solutions offered; EV tyre life is 5-10% shorter vs ICE due to high torque and heavy load.
Company-Specific & Strategic Commentary
- Capacity Expansion: ₹4,980 crore CapEx announced for PCR and TBR at JK Tyre plant; FY27 additions ~7% of current total capacity primarily in TBR and PCR balancing at Balmorheb Tyre Industries; new PCR capacity to be fully ramped up by Q3 FY27.
- Premiumization & Product Excellence: Increasing share of higher value-added products, EV-oriented portfolio, and 16-inch+ PCR (35% of PCR mix) to drive margins alongside price hikes.
- Digital & Manufacturing Excellence: Leveraging IoT, AI, and ML for manufacturing efficiency; mobility business (connected/intelligent solutions) registering high double-digit growth; pan-India roadside ecosystem of 100+ truck wheels and 700+ pit stops.
- Rural Distribution Expansion: Strategically expanding rural distribution network to capture rising vehicle ownership and tyre demand from rural markets.
- Sustainability & Partnerships: International benchmark in raw water usage and energy consumption; British Safety Council international safety award for Vikram and Chennai plants; CII recognition for sustainability/EHS; MOU signed with National Institute of Engineering, Mysore for AI/data-driven tire innovation at RPS CoE.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Revenue Growth | Double-digit growth FY27 | Supported by price increases (~11% cumulative taken, 5-6% further planned) plus volume growth; new PCR capacity fully ramped by Q3 FY27 |
| EBITDA Margin | ~10-11% FY27; 11-13% H2 | Q1 at 6.8% was trough; progressive improvement from Q2 onward as high-priced inventory is consumed; price hikes expected to cover RM inflation barring ~1-2% offset via cost measures |
| Mexico Revenue | Similar top-line to prior year by FY27 end | Production normalized post disruptions; pricing pass-through in Mexico more difficult than India |
| Net Debt | +₹500-700 crore in FY27 | CapEx-led long-term loan disbursements plus working capital needs from higher RM/selling prices; partially funded by internal accruals |
| Raw Material Prices | Range-bound; softening | Natural rubber softening expected to continue into next quarter; commodity/crude moderation to lower input costs |
Risks & Constraints
| Risk | Context |
|---|---|
| Raw Material Price Volatility | West Asia crisis drove ~20% QoQ raw material cost spike in Q1; inventory still at high-priced levels. Management covering through price hikes (with possible 1-2% uncovered), cost reduction, and product mix. Natural rubber softening but expected range-bound. |
| Mexico Operational Disruption | Geopolitical shipping disruptions (containers, bead wire from China) and natural rubber +18% impacted Q1 output; labour slowdown resolved. Normalized production restarted; management expects better results but pricing pass-through remains challenging in Mexico. |
| OEM Price Pass-Through Lag | OEM volumes grew 42% but price increases to OEM flow with a lag, deferring margin recovery to subsequent quarters. |
| Debt Increase | Net debt up ₹500 crore QoQ; FY27 guided increase of ₹500-700 crore due to CapEx and working capital. Leverage still comfortable (0.81x net debt/equity, 2.56x net debt/EBITDA). |
Q&A Highlights
Domestic Volume vs Revenue Growth Gap
- Question: How does 25% domestic volume growth reconcile with only ~14% India revenue growth? (Vijay Kumar, Axis Securities)
- Answer: Net effective price increase ~5% on standalone basis; OEM volume growth of 42% has price pass-through lag that will flow in subsequent quarters. (Sanjeev Aggarwal, CFO; Anshuman Singhania, MD)
Mexico Business Outlook and Normalization
- Question: Mexico declined significantly YoY; should we expect improvement and recovery to prior revenue levels? (Vijay Kumar, Axis Securities; Digant Shah, DAM Capital)
- Answer: Q1 impacted by geopolitical input constraints (bead wire from China, containers, natural rubber +18%) and a productivity slowdown (not a strike), both resolved; production back to normal, expecting better sales/profitability in remaining 3 quarters with similar top-line by year-end. USMCA renewed for 10 years, with tariff structure favorable to Mexico. (Bharat Aggarwal, Head-International Trade)
Pricing Strategy and Quantum
- Question: When were price hikes taken and how much flows into Q1 vs forward? (Vijay Kumar, Axis Securities)
- Answer: Price hikes taken on a monthly basis ("inching up" to avoid demand disruption); Q1 ~5%, cumulative ~11% taken to date, further 5-6% to come in coming months. (Anshuman Singhania, MD; Sanjeev Aggarwal, CFO)
FY27 Margin and Revenue Guidance
- Question: Can management quantify expectations for remaining three quarters? (Bharat Bhagnani, Living Root Analytics)
- Answer: High-priced inventory is being consumed; margins to progressively improve from Q2 with H2 back to normal 11-13% range; full year ~10-11% EBITDA margin; expected double-digit revenue growth from price + volume. (Sanjeev Aggarwal, CFO)
Capacity Utilization and FY27 Additions
- Question: What is capacity utilization across segments and how much volume will new capacity add? (Chirag Jain, Emkay Global)
- Answer: ~95% standalone, ~80% consolidated; TBR near full, PCR 95%, 2-3W and LCV/farm 95%+. FY27 capacity addition ~7% of total, mainly TBR and PCR balancing at Balmorheb plant. (Anshuman Singhania, MD; Sanjeev Aggarwal, CFO)
EV Tyre Replacement Cycle
- Question: Is it true EV tyres have shorter replacement cycles and why? (Chirag Jain, Emkay Global)
- Answer: EV tyres face heavy load and high torque, causing faster wear; life is 5-10% shorter than ICE tyres depending on usage pattern. (Anshuman Singhania, MD; Sanjeev Aggarwal, CFO)
Product Mix Breakdown
- Question: What is the standalone volume mix by product? (Aditi Prajapati, Shah Capital)
- Answer: TBR 56%, PCR 27%, 2-3W 5%, Others (industrial/farm) 12%; PCR 16-inch+ now ~35% of PCL mix, improving. (Sanjeev Aggarwal, CFO)
Key Takeaway
JK Tyre posted a subdued Q1 FY27, with consolidated revenue up only 2% YoY to ₹3,956 crore and EBITDA margin compressing to 6.8% (from 10.9%) as the West Asia crisis drove raw material costs up ~20% QoQ; PAT fell to ₹43 crore. Domestic volumes grew a strong 25% YoY (OEM +42%) despite the input shock, and management countered with ~11% cumulative price hikes (5-6% more planned) while improving mix — PCR 16-inch+ now 35% of PCR volumes. The ₹4,980 crore CapEx program is underway, with ~7% capacity addition (TBR and PCR at Balmorheb) in FY27 and full PCR ramp-up by Q3. Mexico's Tornel operations, hit by supply chain and labour disputes in Q1, have normalized, aided by a 10-year USMCA renewal. Management expects progressive margin recovery from Q2, reaching 11-13% in H2 and ~10-11% for FY27, with double-digit revenue growth and net debt rising ₹500-700 crore. Key watch points remain raw material price trajectory, Mexico pricing pass-through, and OEM price lag.